VitroScan’s proven Predictive Tumor Testing Platform is in clinical development for multiple solid tumors. We closely collaborate with expert clinicians, pathologists, and leading cancer centers to establish the value of our tumor testing services for patients, doctors, and the health care system.
We aim to provide treatment decision support for cancer patients to improve treatment success, prevent unnecessary side effects and reduce the socioeconomic burden of the disease.
VitroScan’s clinical trial program is performed in collaboration with expert oncology clinics. The program covers trials for selected solid cancers, including ovarian cancer, bladder cancer, lung cancer, and pancreatic cancer in which chemo-, targeted, and immunotherapies are tested.
We invite clinical centers that are interested to participate to contact us
VitroScan develops personalized treatment solutions in multiple research collaborations and grant consortia. We are interested to discuss opportunities and to collaborate with partners to enable personalized treatment strategies for cancer patients.